Results 41 to 50 of about 936,523 (298)

Roles of serum and biliary CEA, CA19-9, VEGFR3, and TAC in differentiating between malignant and benign biliary obstructions

The Turkish Journal of Gastroenterology, 2014
Background/Aims: Despite the presence of many diagnostic methods, the differential diagnosis between benign and malignant biliary obstructions is still not easy.
Ali Tüzün İnce, Kemal Yıldız, Birol Baysal, Ahmet Danalıoğlu, Orhan Kocaman, Mukaddes Tozlu, Venkatanarayana Gangarapu, Ahu Sarbay Kemik, Ömer Uysal, Hakan Şentürk   +9 more
doaj   +1 more source

Extreme elevation of CA19-9 in patient with endometriosis-associated cancer: A brief report and review of the literature

Current Problems in Cancer: Case Reports, 2023
CA 19-9 (carbohydrate antigen 19-9) is used as a biomarker for hepatobiliary cancer and is generally not considered helpful in the evaluation of gynecologic cancer.
Maia Drasin, Gregory Rumore, Elizabeth Suh-Burgmann   +2 more
doaj   +1 more source

Carcinoembryonic antigen, CA 19-9, and CA 125 in normal and carcinomatous human colorectal tissue [PDF]

Cancer, 1987
In 115 primary colorectal carcinomas and 64 normal colorectal mucosa specimens the concentrations of carcinoembryonic antigen (CEA), CA 19-9, and CA 125 were measured. The determinations were performed in cytosols by use of radioimmunometric and enzymeimmunometric assays and related to the wet tissue weight.
A, Quentmeier, P, Möller, V, Schwarz, U, Abel, P, Schlag   +4 more
openaire   +2 more sources

The Clinical Relevance of Tumor Marker Cea, Ca 19-9 in Regional Chemotherapy of Hepatic Metastases of Colorectal Carcinoma

The International Journal of Biological Markers, 1988
Up to December 1986, 50 patients with documented hepatic metastases from colorectal carcinoma were treated with 5-fluoro-2-deoxyuridine (FUDR) using Infusaid pumps.
F. Safi, R. Roscher, R. Bittner, H.G. Beger   +3 more
doaj   +1 more source

Clinical significance and revisiting the meaning of CA 19-9 blood level before and after the treatment of pancreatic ductal adenocarcinoma: analysis of 1,446 patients from the pancreatic cancer cohort in a single institution. [PDF]

PLoS ONE, 2013
BACKGROUND: Life expectancy of pancreatic ductal adenocarcinoma (PDAC) patients is usually short and selection of the most appropriate treatment is crucial.
Joo Kyung Park, Woo Hyun Paik, Ji Kon Ryu, Yong-Tae Kim, Youn Joo Kim, Jaihwan Kim, Byeong Jun Song, Jin Myung Park, Yong Bum Yoon   +8 more
doaj   +1 more source

Comparison of CA 19-9 and carcinoembryonic antigen (CEA) levels in the serum of patients with colorectal diseases [PDF]

British Journal of Cancer, 1984
The serum levels of CA 19-9 and carcinoembryonic antigen (CEA) were determined in 37 patients with benign colorectal diseases and in 111 patients with newly discovered colorectal carcinomas or clinically verified relapses. In cancer patients, the CA 19-9 level ranged from normal (0-37 U ml-1) to 77,500 U ml-1 whereas all samples but one from patients ...
P, Kuusela, H, Jalanko, P, Roberts, P, Sipponen, J P, Mecklin, R, Pitkänen, O, Mäkelä   +6 more
openaire   +2 more sources

Diversity and complexity in neural organoids

FEBS Letters, EarlyView.
Neural organoid research aims to expand genetic diversity on one side and increase tissue complexity on the other. Chimeroids integrate multiple donor genomes within single organoids. Self‐organising multi‐identity organoids, exogenous cell seeding, or enforced assembly of region‐specific organoids contribute to tissue complexity.
Ilaria Chiaradia, Madeline A. Lancaster
wiley   +1 more source

EVALUATION OF THE ASSOCIATION OF TUMOR BIOMARKERS WITH CHILDHOOD CANCERS

Hematology, Transfusion and Cell Therapy
Objective: We aimed to investigate the indications for Carbohydrate antigen 19-9 (CA 19-9), carbohydrate antigen 125 (CA-125), carbohydrate antigen 15-3 (CA15-3) and carcinoembryogenic antigen (CEA) tumor biomarkers, less commonly used in children, and ...
Şule ÇALIŞKAN KAMIŞ, Metin ÇİL, Begül YAĞCI KÜPELİ   +2 more
doaj   +1 more source

Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

Frontiers in Oncology, 2013
Background:Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median ...
Uwe ePelzer, Andreas eHilbig, Jens eStieler, Marianne eSinn, Marcus eBahra, Bernd eDörken, Hanno eRiess   +6 more
doaj   +1 more source

Kolesistektomi sonrası uzamış CA 19-9 yüksekliği: olgu sunumu [PDF]

, 2009
Karbonhidrat antijeni 19-9 (CA19-9) gliko spingo lipid yapıda olup serum tümör belirteci olarak bilinir. CA19-9 pankreatik, bilier, hepatosellüler ve gastrointestinal sistem kanserlerinde kullanılan bir tümör belirleyici olmasına ragmen pankreatit ve ...
Ceylan, Cengiz, Turtay, Muhammet Gökhan
core